openPR Logo
Press release

Sudeep Pharma Private Limited Expands into Energy Industry with New Entity Sudeep Advanced Materials Focused on Green Iron Phosphate for EVs

10-01-2024 01:45 PM CET | Energy & Environment

Press release from: Sudeep Advanced Materials

Sudeep Pharma Private Limited Expands into Energy Industry with New  Entity Sudeep Advanced Materials Focused on Green Iron Phosph

Sudeep Pharma Private Limited Expands into Energy Industry with New Entity Sudeep Advanced Materials Focused on Green Iron Phosph

Vadodara, Gujarat - [01/10/2024] - Sudeep Pharma Private Limited (Sudeep Pharma) announces its expansion into the Battery Energy Storage Systems (BESS) industry with the launch of its subsidiary, Sudeep Advanced Materials (SAM). This self-funded project will focus on the production of Green Iron Phosphate, leveraging the company's decades of experience in phosphate manufacturing to
support electric vehicle (EV) and energy storage applications.

Sudeep Pharma began producing Iron Phosphate approximately nine years ago in 2015 and is now one of the largest global producers of food-grade Iron Phosphate, with a capacity of 15,000 MT. Over this period, the company has developed a green process that significantly reduces water consumption and gas emissions. SAM will utilize these capabilities to manufacture Green Iron Phosphate for electric vehicles (EVs) and battery storage systems.

The company has established a Customer Qualification Hub which will validate product specifications and performance with potential customers, laying the groundwork for future commercial production. A 30-acre Commercialization Hub, designed to produce 100,000 metric tonnes (annually) of pCAMs, including Iron Phosphate and Manganese Derivatives, will begin phase 1 production by 2026.

SAM benefits from the Sudeep Pharma's established raw material sourcing capabilities, including Phosphoric Acid, which the company has been procuring for over three decades, ensuring constant supply for its manufacturing processes.

Julian Dunn, Vice President of Sales and Marketing, comments, "The launch of SAM represents a strategic move into the Global battery Market, building on our strong foundation in phosphate manufacturing."

Shanil Bhayani, Director, stated, "Our commitment to sustainability and societal impact has been a cornerstone of our work in the nutrition and food sectors. With SAM, we aim to drive forward innovative, sustainable solutions for battery technologies."

Sudeep Advanced Materials Private Limited,
Sears Tower 2, 601 - 602, East Wing, Gotri-Sevasi Main Road, Sevasi, Vadodara, Gujarat, 391101.
Contact Information:
Sumit Mehetre - Marketing Manager
Phone: +91 70206 81677
Email: Sumit.mehetre@sudeepgroup.com

About Sudeep Pharma Private Limited

Established in 1989, Sudeep Pharma specializes in manufacturing harmaceutical excipients, minerals, and specialty ingredients for the pharma, food, and nutrition industries. As an innovation-driven and technology-led company, Sudeep Pharma utilizes six in-house fine-tuned and engineered technologies
in its manufacturing processes. With a diverse portfolio of over 200 products and a customer base exceeding 1,000 across more than 80 countries, the Company maintains a strong international presence with sales offices in the US and Europe.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sudeep Pharma Private Limited Expands into Energy Industry with New Entity Sudeep Advanced Materials Focused on Green Iron Phosphate for EVs here

News-ID: 3672141 • Views: …

More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 π‰πžπ«π¬πžπ²- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDΒ 22.32Β Billion by 2024. The valuation is expected to reach USDΒ 47.79Β Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 π‰πžπ«π¬πžπ²- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 π‰πžπ«π¬πžπ²- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…